New multiple myeloma treatment approved in the U.S.
In June 2019, the U.S. FDA approved selinexor (Xpovio) in combination with dexamethasone for the treatment of relapsed or refractory multiple myeloma. Myeloma patients had… Read More
Science & Research
This is my archive
Latest grants announced in Australia-US blood cancer research co-funding partnership
Two new research projects co-funded through a partnership between America’s The Leukemia & Lymphoma Society (LLS), Snowdome Foundation and Leukaemia Foundation will focus on acute… Read More
Professor John Pimanda – Expediting drug discovery in MDS
Professor Pimanda is incredibly curious. His observations around why cells behave in certain ways and respond variably to stimuli led him down a cell biology… Read More
Prof Ravi Majeti and Dr Daniel Thomas are uncovering new methods to switch off and destroy cancer cells.
Genetics is complex! At a very basic level we understand that when genes are altered or mutated the end result is a disease. This can… Read More
Prof Mark Dawson receives Frank Fenner Prize for Life Scientist of the Year
Professor Mark Dawson has been awarded the 2020 Frank Fenner Prize for Life Scientist of the Year. This prestigious award is one of the Australian… Read More
Fellowships provide our Australian researchers with time to do what they do best – Research
For the first time, the Snowdome Foundation pivoted its annual Blood Sweat and Tears of Joy educational event from face-to-face to virtual. This increased access… Read More
FDA approves 6 new blood cancer treatments in the last 3 months
Since June 2020 the FDA has approved 6 new blood cancer treatments and expanded the use of an already available treatment. Sadly none are approved… Read More
CAR-T cell therapy clinical trials provide more hope for lymphoma and leukaemia patients
Dr Michael Dickinson is the Lead of the Aggressive Lymphoma disease group within Clinical Haematology at Peter MacCallum Cancer Centre and Royal Melbourne Hospital. Michael… Read More
Funding a Fellow in Western Australia to provide hope through more blood cancer clinical trials
Four years ago, if you had a blood cancer in Western Australia (WA) and needed access to the latest treatment via a clinical trial, you… Read More
CAR-T cell treatment for multiple myeloma – the landscape so far
Chimeric Antigen Receptor (CAR) T cell therapy has been approved in Australia for forms of leukaemia and lymphoma for a while now, but we are… Read More
